Adaptive Capital Partners logo

Adaptive Capital Partners

Asia, Central Region, Singapore, Singapore

Description

Adaptive Capital Partners is a early-stage technology focused venture capital firm.

Investor Profile

Adaptive Capital Partners has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Adaptive Capital Partners frequently co-invest with?

FemHealth Ventures
North America, New York, United States, New York
Co-Investments: 1
RH Capital
North America, California, United States, San Francisco
Co-Investments: 1
Cancer Fund
North America, Arizona, United States, Phoenix
Co-Investments: 1
The Helm
North America, New York, United States, New York
Co-Investments: 1
Gore Range Capital
North America, New York, United States, New York
Co-Investments: 1
Good Growth Capital
North America, South Carolina, United States, Charleston
Co-Investments: 1
Astia
North America, California, United States, San Francisco
Co-Investments: 1
LabCorp Venture Fund
North America, North Carolina, United States, Burlington
Co-Investments: 1
LongeVC
Europe, Ticino, Switzerland, Lugano
Co-Investments: 1
VU Venture Partners
North America, California, United States, San Francisco
Co-Investments: 1

What are some of recent deals done by Adaptive Capital Partners?

AOA

Boulder, Colorado, United States

AOA Dx is a biotech company developing cancer diagnostics in the field of women’s health.

BiotechnologyHealth CareHealth Diagnostics
Series AOct 11, 2023
Amount Raised: $17,000,000